Latest BioPharma News and In-Depth Analysis | BioPharma BoardRoom

22 December, 2024 | Sunday

Which controlled pore glass is right for your therapeutic application?

Oligonucleotide therapeutics have unlocked new treatment possibilities for rare and fatal diseases often associated with undruggable proteins.1 Here, ...

April 01, 2023 | Saturday | Analysis

1
2
3
4

Partner Content

Maximize Time for Innovation: Strategies for Reducing Non-Core Tasks in the Lab
09 August, 2024
Extractables in single-use systems used in ADC manufacturing
19 June, 2024
Empower the Next Wave of Pharmaceutical Breakthroughs with Molecule GEN's AI-Driven Innovation
13 February, 2024
Unleash the Future of Drug Discovery with Molecule GEN: Your AI Odyssey Begins Here!
03 December, 2024
Three Ways Chromatography Data System Software Drives the Lab of the Future
23 October, 2024

BioPharma BreakThrough's

Editor Picks

Agilent Drives Strategic Transformation with Strong FY2024 Results, CEO Padraig McDonnell Leads Restructuring for Market Agility and Growth
26 November, 2024
Merck CEO Belén Garijo Declares Strong Q3 2024 Growth, Reaffirms Path to Profitable 2024 Finish
21 November, 2024
CEO Adam Levy Announces Record-Breaking Q3 Revenue for NEXGEL with 141% Year-Over-Year Growth to $2.94 Million
14 November, 2024
Pfizer Appoints Dr. Chris Boshoff to Lead Global R&D Strategy, Pursuing Breakthroughs in Oncology and Beyond
21 November, 2024
Trump’s Back – And Pharma’s Price Tags Might Be in for a Reality Check
07 November, 2024

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

Gene Editing Breakthroughs

Innovative Drug Discovery

Vaccine Development

Biologics and Therapeutic Antibodies

× Please select an option to participate in the poll.

View poll results More polls

× You have successfully cast your vote.

{{ optionDetail.option }} {{ optionDetail.percentage }}%

More polls

About Us Media Pack Contact Us Privacy Policy

© 2024 Biopharma Boardroom. All Rights Reserved.